[CLDX] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
02-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -25.43%
YoY- -42.85%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 2,498 156 4,131 1,517 268 967 1,613 33.89%
PBT -35,842 -32,808 -43,306 -38,260 -30,502 -29,361 -26,487 22.36%
Tax 0 732 13,384 -2,979 -3,459 -6,946 -2,796 -
NP -35,842 -32,808 -43,306 -38,260 -30,502 -22,415 -23,691 31.82%
Tax Rate - - - - - - - -
Total Cost 38,340 32,964 47,437 39,777 30,770 23,382 25,304 31.95%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin -1,434.83 -21,030.77 -1,048.32 -2,522.08 -11,381.34 -2,317.99 -1,468.75 -1.54%
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.54 -0.56 -0.83 -0.81 -0.65 -0.47 -0.50 5.26%
EPS Diluted -0.54 -0.56 -0.83 -0.81 -0.65 -0.47 -0.50 5.26%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.